Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

UC781 microbicide gel retains anti-HIV activity in cervicovaginal lavage fluids collected following twice-daily vaginal application.

Haaland RE, Evans-Strickfaden T, Holder A, Pau CP, McNicholl JM, Chaikummao S, Chonwattana W, Hart CE.

Antimicrob Agents Chemother. 2012 Jul;56(7):3592-6. doi: 10.1128/AAC.00452-12. Epub 2012 Apr 16.

2.

Clinical development of microbicides for the prevention of HIV infection.

D'Cruz OJ, Uckun FM.

Curr Pharm Des. 2004;10(3):315-36. Review.

PMID:
14754390
3.

Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.

Garg S, Goldman D, Krumme M, Rohan LC, Smoot S, Friend DR.

Antiviral Res. 2010 Dec;88 Suppl 1:S19-29. doi: 10.1016/j.antiviral.2010.09.010. Review.

PMID:
21109064
4.

Preclinical assessments of vaginal microbicide candidate safety and efficacy.

Fernández-Romero JA, Teleshova N, Zydowsky TM, Robbiani M.

Adv Drug Deliv Rev. 2015 Sep 15;92:27-38. doi: 10.1016/j.addr.2014.12.005. Epub 2014 Dec 24. Review.

5.

Guiding the vaginal microbicide trials with biomarkers of inflammation.

Fichorova RN.

J Acquir Immune Defic Syndr. 2004 Oct;37 Suppl 3:S184-93. Review.

6.

Vaginal drug distribution modeling.

Katz DF, Yuan A, Gao Y.

Adv Drug Deliv Rev. 2015 Sep 15;92:2-13. doi: 10.1016/j.addr.2015.04.017. Epub 2015 Apr 28. Review.

7.

Vaginal films for drug delivery.

Machado RM, Palmeira-de-Oliveira A, Martinez-De-Oliveira J, Palmeira-de-Oliveira R.

J Pharm Sci. 2013 Jul;102(7):2069-81. doi: 10.1002/jps.23577. Epub 2013 May 6. Review.

PMID:
23649325
Items per page

Supplemental Content

Write to the Help Desk